Description
The number of children taking second-generation antipsychotics (SGA) is increasing. While SGAs produce fewer neurological side effects, the metabolic side effects of SGAs increase the risk for future cardiometabolic disease.
Copyright Statement
Download count: 0
Details
Contributors
- Tinkey, Janet (Author)
- Guthery, Ann (Thesis advisor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2018-04-21
Resource Type
Collections this item is in
Collaborating institutions